Development of64Cu-NOTA-Trastuzumab for HER2 targeting: radiopharmaceutical with improved pharmacokinetics for human study

Title
Development of64Cu-NOTA-Trastuzumab for HER2 targeting: radiopharmaceutical with improved pharmacokinetics for human study
Authors
Keywords
-
Journal
JOURNAL OF NUCLEAR MEDICINE
Volume -, Issue -, Pages jnumed.118.210294
Publisher
Society of Nuclear Medicine
Online
2018-05-19
DOI
10.2967/jnumed.118.210294

Ask authors/readers for more resources

Discover Peeref hubs

Discuss science. Find collaborators. Network.

Join a conversation

Ask a Question. Answer a Question.

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started